111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
until further notice
SourceEuropean Journal of Nuclear Medicine and Molecular Imaging, 37, 7, (2010), pp. 1441-1448
1 juli 2010
Article / Letter to editor
Display more detailsDisplay less details
European Journal of Nuclear Medicine and Molecular Imaging
SubjectONCOL 3: Translational research
This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.